Canonical Inflammasomes.

Christgen S, Place DE, Kanneganti T-D (2020) Toward targeting inflammasomes: insights into their regulation and activation. Cell Res 30(4):315–327. https://doi.org/10.1038/s41422-020-0295-8

doi: 10.1038/s41422-020-0295-8 pubmed: 32152420 pmcid: 7118104

Lu A, Magupalli Venkat G, Ruan J, Yin Q, Atianand Maninjay K, Vos MR et al (2014) Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156(6):1193–1206. https://doi.org/10.1016/j.cell.2014.02.008

doi: 10.1016/j.cell.2014.02.008 pubmed: 24630722 pmcid: 4000066

Stutz A, Horvath GL, Monks BG, Latz E (2013) ASC speck formation as a readout for inflammasome activation. Methods Mol Biol 1040:91 –101. https://doi.org/10.1007/978-1-62703-523-1_8

doi: 10.1007/978-1-62703-523-1_8 pubmed: 23852599

Chan AH, Schroder K (2019) Inflammasome signaling and regulation of interleukin-1 family cytokines. J Exp Med 217(1):e20190314. https://doi.org/10.1084/jem.20190314

doi: 10.1084/jem.20190314 pmcid: 7037238

Shi J, Gao W, Shao F (2017) Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci 42(4):245–254. https://doi.org/10.1016/j.tibs.2016.10.004

doi: 10.1016/j.tibs.2016.10.004 pubmed: 27932073

Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10(2):417–426

doi: 10.1016/S1097-2765(02)00599-3 pubmed: 12191486

Taabazuing CY, Griswold AR, Bachovchin DA (2020) The NLRP1 and CARD8 inflammasomes. Immunol Rev 297(1):13–25. https://doi.org/10.1111/imr.12884

doi: 10.1111/imr.12884 pubmed: 32558991 pmcid: 7483925

Yu CH, Moecking J, Geyer M, Masters SL (2018) Mechanisms of NLRP1-mediated autoinflammatory disease in humans and mice. J Mol Biol 430(2):142–152. https://doi.org/10.1016/j.jmb.2017.07.012

doi: 10.1016/j.jmb.2017.07.012 pubmed: 28733143

Zhong FL, Mamaï O, Sborgi L, Boussofara L, Hopkins R, Robinson K et al (2016) Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via Inflammasome activation. Cell 167(1):187–202.e17. https://doi.org/10.1016/j.cell.2016.09.001

doi: 10.1016/j.cell.2016.09.001 pubmed: 27662089

Chavarría-Smith J, Mitchell PS, Ho AM, Daugherty MD, Vance RE (2016) Functional and evolutionary analyses identify proteolysis as a general mechanism for NLRP1 Inflammasome activation. PLoS Pathog 12(12):e1006052. https://doi.org/10.1371/journal.ppat.1006052

doi: 10.1371/journal.ppat.1006052 pubmed: 27926929 pmcid: 5142783

Finger JN, Lich JD, Dare LC, Cook MN, Brown KK, Duraiswami C et al (2012) Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity. J Biol Chem 287(30):25030–25037. https://doi.org/10.1074/jbc.M112.378323

doi: 10.1074/jbc.M112.378323 pubmed: 22665479 pmcid: 3408201

Sandstrom A, Mitchell PS, Goers L, Mu EW, Lesser CF, Vance RE (2019) Functional degradation: a mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes. Science (New York, NY) 364(6435). https://doi.org/10.1126/science.aau1330

Lopes Fischer N, Naseer N, Shin S, Brodsky IE (2020) Effector-triggered immunity and pathogen sensing in metazoans. Nat Microbiol 5(1):14–26. https://doi.org/10.1038/s41564-019-0623-2

doi: 10.1038/s41564-019-0623-2 pubmed: 31857733

Robinson KS, Teo DET, Tan KS, Toh GA, Ong HH, Lim CK et al (2020) Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia. Science (New York, NY) 370(6521). https://doi.org/10.1126/science.aay2002

Tsu BV, Beierschmitt C, Ryan AP, Agarwal R, Mitchell PS, Daugherty MD (2021) Diverse viral proteases activate the NLRP1 inflammasome. elife:10. https://doi.org/10.7554/eLife.60609

Bauernfried S, Scherr MJ, Pichlmair A, Duderstadt KE, Hornung V (2021) Human NLRP1 is a sensor for double-stranded RNA. Science (New York, NY) 371(6528). https://doi.org/10.1126/science.abd0811

Zhong FL, Robinson K, Teo DET, Tan KY, Lim C, Harapas CR et al (2018) Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding. 293(49):18864–18878. https://doi.org/10.1074/jbc.RA118.004350

Griswold AR, Ball DP, Bhattacharjee A, Chui AJ, Rao SD, Taabazuing CY et al (2019) DPP9’s enzymatic activity and not its binding to CARD8 inhibits Inflammasome activation. ACS Chem Biol 14(11):2424–2429. https://doi.org/10.1021/acschembio.9b00462

doi: 10.1021/acschembio.9b00462 pubmed: 31525884 pmcid: 6862324

Gai K, Okondo MC, Rao SD, Chui AJ, Ball DP, Johnson DC et al (2019) DPP8/9 inhibitors are universal activators of functional NLRP1 alleles. Cell Death Dis 10(8):587. https://doi.org/10.1038/s41419-019-1817-5

doi: 10.1038/s41419-019-1817-5 pubmed: 31383852 pmcid: 6683174

Costa FRC, Leite JA, Rassi DM, da Silva JF, Elias-Oliveira J, Guimarães JB et al (2021) NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes. Cell Rep 35(8). https://doi.org/10.1016/j.celrep.2021.109176

Ting JP, Duncan JA, Lei Y (2010) How the noninflammasome NLRs function in the innate immune system. Science (New York, NY) 327(5963):286–290. https://doi.org/10.1126/science.1184004

doi: 10.1126/science.1184004

Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F et al (2007) Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 55(5):443–452. https://doi.org/10.1369/jhc.6A7101.2006

doi: 10.1369/jhc.6A7101.2006 pubmed: 17164409

Okondo MC, Rao SD, Taabazuing CY, Chui AJ, Poplawski SE, Johnson DC et al (2018) Inhibition of Dpp8/9 activates the Nlrp1b Inflammasome. Cell Chem Biol 25(3):262–7.e5. https://doi.org/10.1016/j.chembiol.2017.12.013

doi: 10.1016/j.chembiol.2017.12.013 pubmed: 29396289 pmcid: 5856610

Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17(13):1140–1145. https://doi.org/10.1016/j.cub.2007.05.074

doi: 10.1016/j.cub.2007.05.074 pubmed: 17600714

Yap JKY, Pickard BS, Chan EWL, Gan SY (2019) The role of neuronal NLRP1 Inflammasome in Alzheimer’s disease: bringing neurons into the Neuroinflammation game. Mol Neurobiol 56(11):7741–7753. https://doi.org/10.1007/s12035-019-1638-7

doi: 10.1007/s12035-019-1638-7 pubmed: 31111399

Sand J, Haertel E, Biedermann T, Contassot E, Reichmann E, French LE et al (2018) Expression of inflammasome proteins and inflammasome activation occurs in human, but not in murine keratinocytes. Cell Death Dis 9(2):24. https://doi.org/10.1038/s41419-017-0009-4

doi: 10.1038/s41419-017-0009-4 pubmed: 29348630 pmcid: 5833864

Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 Inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20(13):3328. https://doi.org/10.3390/ijms20133328

doi: 10.3390/ijms20133328 pubmed: 31284572 pmcid: 6651423

Hayward JA, Mathur A, Ngo C, Man SM (2018) Cytosolic recognition of microbes and pathogens: Inflammasomes in action. Microbiol Mol Biol Rev 82(4). https://doi.org/10.1128/mmbr.00015-18

Sharma M, de Alba E (2021) Structure, activation and regulation of NLRP3 and AIM2 inflammasomes. Int J Mol Sci 22(2). https://doi.org/10.3390/ijms22020872

Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q et al (2019) Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature 570(7761):338–343. https://doi.org/10.1038/s41586-019-1295-z

doi: 10.1038/s41586-019-1295-z pubmed: 31189953 pmcid: 6774351

Aksentijevich I, Putnam CD, Remmers EF, Mueller JL, Le J, Kolodner RD et al (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in north American patients and a new cryopyrin model. Arthritis Rheum 56(4):1273–1285. https://doi.org/10.1002/art.22491

doi: 10.1002/art.22491 pubmed: 17393462 pmcid: 4321998

Hafner-Bratkovič I, Sušjan P, Lainšček D, Tapia-Abellán A, Cerović K, Kadunc L et al (2018) NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway. Nat Commun 9(1):5182. https://doi.org/10.1038/s41467-018-07573-4

doi: 10.1038/s41467-018-07573-4 pubmed: 30518920 pmcid: 6281599

Mayor A, Martinon F, De Smedt T, Pétrilli V, Tschopp J (2007) A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat Immunol 8(5):497–503. https://doi.org/10.1038/ni1459

doi: 10.1038/ni1459 pubmed: 17435760

Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P, Alice in caspase land. (2002) A phylogenetic analysis of caspases from worm to man. Cell Death Differ 9(4):358–361. https://doi.org/10.1038/sj.cdd.4400989

doi: 10.1038/sj.cdd.4400989 pubmed: 11965488

Lopez-Castejon G (2020) Control of the inflammasome by the ubiquitin system. FEBS J 287(1):11–26. https://doi.org/10.1111/febs.15118

doi: 10.1111/febs.15118 pubmed: 31679183

He Y, Zeng MY, Yang D, Motro B, Núñez G (2016) NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530(7590):354–357. https://doi.org/10.1038/nature16959

doi: 10.1038/nature16959 pubmed: 26814970 pmcid: 4810788

Niu T, De Rosny C, Chautard S, Rey A, Patoli D, Groslambert M et al (2021) NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly. Nat Commun 12(1):5862. https://doi.org/10.1038/s41467-021-26142-w

doi: 10.1038/s41467-021-26142-w pubmed: 34615873 pmcid: 8494922

Weber ANR, Bittner ZA, Shankar S, Liu X, Chang TH, Jin T et al (2020) Recent insights into the regulatory networks of NLRP3 inflammasome activation. J Cell Sci 133(23). https://doi.org/10.1242/jcs.248344

Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47(1):15–31. https://doi.org/10.1016/j.immuni.2017.06.020

doi: 10.1016/j.immuni.2017.06.020 pubmed: 28723547

Di A, Xiong S, Ye Z, Malireddi RKS, Kometani S, Zhong M et al (2018) The TWIK2 potassium Efflux Channel in macrophages mediates NLRP3 Inflammasome-induced inflammation. Immunity 49(1):56–65.e4. https://doi.org/10.1016/j.immuni.2018.04.032

doi: 10.1016/j.immuni.2018.04.032 pubmed: 29958799 pmcid: 6051907

Mayes-Hopfinger L, Enache A, Xie J, Huang C-L, Köchl R, Tybulewicz VLJ et al (2021) Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis. Nat Commun 12(1):4546. https://doi.org/10.1038/s41467-021-24784-4

doi: 10.1038/s41467-021-24784-4 pubmed: 34315884 pmcid: 8316491

Wang L, Negro R, Wu H (2020) TRPM2, linking oxidative stress and ca(2+) permeation to NLRP3 inflammasome activation. Curr Opin Immunol 62:131 –135. https://doi.org/10.1016/j.coi.2020.01.005

doi: 10.1016/j.coi.2020.01.005 pubmed: 32058297 pmcid: 7533107

Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S et al (2020) Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat Immunol 21(1):30–41. https://doi.org/10.1038/s41590-019-0548-1

doi: 10.1038/s41590-019-0548-1 pubmed: 31819254

Green JP, Yu S, Martín-Sánchez F, Pelegrin P, Lopez-Castejon G, Lawrence CB et al (2018) Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Proc Natl Acad Sci U S A 115(40):E9371–E9e80. https://doi.org/10.1073/pnas.1812744115

doi: 10.1073/pnas.1812744115 pubmed: 30232264 pmcid: 6176575

Mohanty A, Tiwari-Pandey R, Pandey NR (2019) Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response. J Cell Commun Signal 13(3):303–318. https://doi.org/10.1007/s12079-019-00507-9

doi: 10.1007/s12079-019-00507-9 pubmed: 30719617 pmcid: 6732146

Meyers AK, Zhu X (2020) The NLRP3 Inflammasome: metabolic regulation and contribution to Inflammaging. Cell 9(8):1808. https://doi.org/10.3390/cells9081808

doi: 10.3390/cells9081808

Hughes MM, O’Neill LAJ (2018) Metabolic regulation of NLRP3. Immunol Rev 281(1):88–98. https://doi.org/10.1111/imr.12608

doi: 10.1111/imr.12608 pubmed: 29247992

Chevriaux A, Pilot T, Derangère V, Simonin H, Martine P, Chalmin F et al (2020) Cathepsin B is required for NLRP3 Inflammasome activation in macrophages, through NLRP3. Interaction:8. https://doi.org/10.3389/fcell.2020.00167

Gross O, Poeck H, Bscheider M, Dostert C, Hannesschläger N, Endres S et al (2009) Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459(7245):433–436. https://doi.org/10.1038/nature07965

doi: 10.1038/nature07965 pubmed: 19339971

Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J et al (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479(7371):117–121. https://doi.org/10.1038/nature10558

doi: 10.1038/nature10558 pubmed: 22002608

Viganò E, Diamond CE, Spreafico R, Balachander A, Sobota RM, Mortellaro A (2015) Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun 6(1):8761. https://doi.org/10.1038/ncomms9761

doi: 10.1038/ncomms9761 pubmed: 26508369

Gaidt MM, Ebert TS, Chauhan D, Schmidt T, Schmid-Burgk JL, Rapino F et al (2016) Human monocytes engage an alternative Inflammasome pathway. Immunity 44(4):833–846. https://doi.org/10.1016/j.immuni.2016.01.012

doi: 10.1016/j.immuni.2016.01.012 pubmed: 27037191

Tyrkalska SD, Candel S, Mulero V (2021) The neutrophil inflammasome. Dev Comp Immunol 115:103874 . https://doi.org/10.1016/j.dci.2020.103874

doi: 10.1016/j.dci.2020.103874 pubmed: 32987011

Nakamura Y, Kambe N, Saito M, Nishikomori R, Kim Y-G, Murakami M et al (2009) Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 206(5):1037–1046. https://doi.org/10.1084/jem.20082179

doi: 10.1084/jem.20082179 pubmed: 19364881 pmcid: 2715029

Bonnekoh H, Scheffel J, Kambe N, Krause K (2018) The role of mast cells in autoinflammation. Immunol Rev 282(1):265–275. https://doi.org/10.1111/imr.12633

doi: 10.1111/imr.12633 pubmed: 29431217

Kumar H, Kumagai Y, Tsuchida T, Koenig PA, Satoh T, Guo Z et al (2009) Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J Immunol (Baltimore, Md: 1950) 183(12):8061–8067. https://doi.org/10.4049/jimmunol.0902477

doi: 10.4049/jimmunol.0902477

Ali MF, Dasari H, Van Keulen VP, Carmona EM (2017) Canonical stimulation of the NLRP3 Inflammasome by fungal antigens links innate and adaptive B-lymphocyte responses by modulating IL-1β and IgM production. Front Immunol 8:1504 . https://doi.org/10.3389/fimmu.2017.01504

doi: 10.3389/fimmu.2017.01504 pubmed: 29170665 pmcid: 5684107

Arbore G, West EE, Spolski R, Robertson AAB, Klos A, Rheinheimer C et al (2016) T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells. Science (New York, NY) 352(6292):aad1210. https://doi.org/10.1126/science.aad1210

doi: 10.1126/science.aad1210

Arbore G, West EE, Rahman J, Le Friec G, Niyonzima N, Pirooznia M (2018) Complement receptor CD46 co-stimulates optimal human CD8(+) T cell effector function via fatty acid metabolism. 9(1):4186. https://doi.org/10.1038/s41467-018-06706-z

Fong JJ, Tsai CM, Saha S, Nizet V, Varki A, Bui JD (2018) Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cells. Proc Natl Acad Sci U S A 115(41):10410–10415. https://doi.org/10.1073/pnas.1804108115

doi: 10.1073/pnas.1804108115 pubmed: 30254166 pmcid: 6187154

Hottz ED, Monteiro APT, Bozza FA, Bozza PT (2015) Inflammasome in platelets: allying coagulation and inflammation in infectious and sterile diseases? Mediat Inflamm 2015:435783 . https://doi.org/10.1155/2015/435783

doi: 10.1155/2015/435783

He Y, Franchi L, Núñez G (2013) TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol. (Baltimore, Md: 1950) 190(1):334–339. https://doi.org/10.4049/jimmunol.1202737

doi: 10.4049/jimmunol.1202737 pubmed: 23225887

Tourneur L, Witko-Sarsat V (2019) Inflammasome activation: neutrophils go their own way. 105(3):433–436. https://doi.org/10.1002/JLB.3CE1118-433R

Bruchard M, Rebe C, Derangere V, Togbe D, Ryffel B, Boidot R et al (2015) The receptor NLRP3 is a transcriptional regulator of TH2 differentiation 16(8):859–870. https://doi.org/10.1038/ni.3202

doi: 10.1038/ni.3202

Netea MG, Domínguez-Andrés J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E et al (2020) Defining trained immunity and its role in health and disease. Nat Rev Immunol 20(6):375–388. https://doi.org/10.1038/s41577-020-0285-6

doi: 10.1038/s41577-020-0285-6 pubmed: 32132681 pmcid: 7186935

Vande Walle L, Van Opdenbosch N, Jacques P, Fossoul A, Verheugen E, Vogel P et al (2014) Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 512(7512):69–73. https://doi.org/10.1038/nature13322

doi: 10.1038/nature13322 pubmed: 25043000

Bauernfeind F, Rieger A, Schildberg FA, Knolle PA, Schmid-Burgk JL, Hornung V (2012) NLRP3 inflammasome activity is negatively controlled by miR-223. J Immunol. (Baltimore, Md: 1950) 189(8):4175–4181. https://doi.org/10.4049/jimmunol.1201516

doi: 10.4049/jimmunol.1201516 pubmed: 22984082

Stehlik C, Krajewska M, Welsh K, Krajewski S, Godzik A, Reed JC (2003) The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation. Biochem J 373(Pt 1):101–113. https://doi.org/10.1042/bj20030304

doi: 10.1042/bj20030304 pubmed: 12656673 pmcid: 1223462

Dorfleutner A, Bryan NB, Talbott SJ, Funya KN, Rellick SL, Reed JC et al (2007) Cellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activation. Infect Immun 75(3):1484–1492. https://doi.org/10.1128/iai.01315-06

doi: 10.1128/iai.01315-06 pubmed: 17178784

Eren E, Berber M, Özören N (2017) NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding. J Biol Chem 292(30):12691–12701. https://doi.org/10.1074/jbc.M116.769695

doi: 10.1074/jbc.M116.769695 pubmed: 28584053 pmcid: 5535042

Seok JK, Kang HC, Cho Y-Y, Lee HS, Lee JY (2021) Regulation of the NLRP3 Inflammasome by post-translational modifications and. Small Molecules 11. https://doi.org/10.3389/fimmu.2020.618231

Jackson JT, Mulazzani E, Nutt SL, Masters SL (2021) The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration. J Biol Chem 297(2). https://doi.org/10.1016/j.jbc.2021.100905

Tang J, Tu S, Lin G, Guo H, Yan C, Liu Q et al (2020) Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia. J Exp Med 217(4). https://doi.org/10.1084/jem.20182091

Wan P, Zhang Q, Liu W, Jia Y, Ai S, Wang T et al (2019) Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation. FASEB J 33(4):5793–5807. https://doi.org/10.1096/fj.201801681R

doi: 10.1096/fj.201801681R pubmed: 30653357

Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z et al (2015) Dopamine controls systemic inflammation through inhibition of NLRP3 Inflammasome. Cell 160(1):62–73. https://doi.org/10.1016/j.cell.2014.11.047

doi: 10.1016/j.cell.2014.11.047 pubmed: 25594175

Mishra BB, Rathinam VA, Martens GW, Martinot AJ, Kornfeld H, Fitzgerald KA et al (2013) Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat Immunol 14(1):52–60. https://doi.org/10.1038/ni.2474

doi: 10.1038/ni.2474 pubmed: 23160153

Sokolowska M, Chen LY, Liu Y, Martinez-Anton A, Qi HY, Logun C et al (2015) Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J Immunol (Baltimore, Md: 1950) 194(11):5472–5487. https://doi.org/10.4049/jimmunol.1401343

doi: 10.4049/jimmunol.1401343

Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science (New York, NY) 356(6337):513–519. https://doi.org/10.1126/science.aal3535

doi: 10.1126/science.aal3535

Salina A, Brandt S, Medeiros AI, Serezani H (2019) Leukotriene B4 is required for inflammasome activation. J Immunol, Suppl 1 202:183 .17

Segovia M, Russo S, Jeldres M, Mahmoud YD, Perez V, Duhalde M et al (2019) Targeting TMEM176B enhances antitumor immunity and augments the efficacy of immune checkpoint blockers by unleashing Inflammasome activation. Cancer Cell 35(5):767–81.e6. https://doi.org/10.1016/j.ccell.2019.04.003

doi: 10.1016/j.ccell.2019.04.003 pubmed: 31085177 pmcid: 6521897

Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozören N, Jagirdar R et al (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7(6):576–582. https://doi.org/10.1038/ni1346

doi: 10.1038/ni1346 pubmed: 16648852

Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430(6996):213–218. https://doi.org/10.1038/nature02664

doi: 10.1038/nature02664 pubmed: 15190255

Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI et al (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7(6):569–575. https://doi.org/10.1038/ni1344

doi: 10.1038/ni1344 pubmed: 16648853

Kofoed EM, Vance RE (2011) Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477(7366):592–595. https://doi.org/10.1038/nature10394

doi: 10.1038/nature10394 pubmed: 21874021 pmcid: 3184209

Lightfield KL, Persson J, Trinidad NJ, Brubaker SW, Kofoed EM, Sauer JD et al (2011) Differential requirements for NAIP5 in activation of the NLRC4 inflammasome. Infect Immun 79(4):1606–1614. https://doi.org/10.1128/iai.01187-10

doi: 10.1128/iai.01187-10 pubmed: 21282416 pmcid: 3067536

Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H et al (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477(7366):596–600. https://doi.org/10.1038/nature10510

doi: 10.1038/nature10510 pubmed: 21918512

Diebolder CA, Halff EF, Koster AJ, Huizinga EG, Koning RI (2015) Cryoelectron tomography of the NAIP5/NLRC4 Inflammasome: implications for NLR activation. Structure (London, England: 1993) 23(12):2349–2357. https://doi.org/10.1016/j.str.2015.10.001

doi: 10.1016/j.str.2015.10.001 pubmed: 26585513

Hu Z, Zhou Q, Zhang C, Fan S, Cheng W, Zhao Y et al (2015) Structural and biochemical basis for induced self-propagation of NLRC4. Science (New York, NY) 350(6259):399–404. https://doi.org/10.1126/science.aac5489

doi: 10.1126/science.aac5489

Zhang L, Chen S, Ruan J, Wu J, Tong AB, Yin Q et al (2015) Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization. Science (New York, NY) 350(6259):404–409. https://doi.org/10.1126/science.aac5789

doi: 10.1126/science.aac5789

Yang J, Zhao Y, Shi J, Shao F (2013) Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc Natl Acad Sci 110(35):14408. https://doi.org/10.1073/pnas.1306376110

doi: 10.1073/pnas.1306376110 pubmed: 23940371 pmcid: 3761597

Kortmann J, Brubaker SW, Monack DM (2015) Cutting edge: Inflammasome activation in primary human macrophages is dependent on Flagellin. J Immunol:1403100. https://doi.org/10.4049/jimmunol.1403100

Wang SB, Narendran S, Hirahara S, Varshney A, Pereira F, Apicella I et al (2021) DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs. Science Immunol 6(66):eabi4493. https://doi.org/10.1126/sciimmunol.abi4493

doi: 10.1126/sciimmunol.abi4493

Man SM, Hopkins LJ, Nugent E, Cox S, Glück IM, Tourlomousis P et al (2014) Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex. Proc Natl Acad Sci 111(20):7403. https://doi.org/10.1073/pnas.1402911111

doi: 10.1073/pnas.1402911111 pubmed: 24803432 pmcid: 4034195

Haloupek N, Grob P, Tenthorey J, Vance RE, Nogales E (2019) Cryo-EM studies of NAIP-NLRC4 inflammasomes. Methods Enzymol 625:177 –204. https://doi.org/10.1016/bs.mie.2019.04.030

doi: 10.1016/bs.mie.2019.04.030 pubmed: 31455527 pmcid: 7025759

Qu Y, Misaghi S, Izrael-Tomasevic A, Newton K, Gilmour LL, Lamkanfi M et al (2012) Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 490(7421):539–542. https://doi.org/10.1038/nature11429

doi: 10.1038/nature11429 pubmed: 22885697

Liu W, Liu X, Li Y, Zhao J, Liu Z, Hu Z et al (2017) LRRK2 promotes the activation of NLRC4 inflammasome during salmonella Typhimurium infection. J Exp Med 214(10):3051–3066. https://doi.org/10.1084/jem.20170014

doi: 10.1084/jem.20170014 pubmed: 28821568 pmcid: 5626397

Li Y, Fu T-M, Lu A, Witt K, Ruan J, Shen C et al (2018) Cryo-EM structures of ASC and NLRC4 CARD filaments reveal a unified mechanism of nucleation and activation of caspase-1. Proc Natl Acad Sci 115(43):10845. https://doi.org/10.1073/pnas.1810524115

doi: 10.1073/pnas.1810524115 pubmed: 30279182 pmcid: 6205419

Im SS, Yousef L, Blaschitz C, Liu JZ, Edwards RA, Young SG et al (2011) Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab 13(5):540–549. https://doi.org/10.1016/j.cmet.2011.04.001

doi: 10.1016/j.cmet.2011.04.001 pubmed: 21531336 pmcid: 3090630

von Moltke J, Trinidad NJ, Moayeri M, Kintzer AF, Wang SB, van Rooijen N et al (2012) Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490(7418):107–111. https://doi.org/10.1038/nature11351

doi: 10.1038/nature11351

Man SM, Tourlomousis P, Hopkins L, Monie TP, Fitzgerald KA, Bryant CE (2013) Salmonella infection induces recruitment of Caspase-8 to the inflammasome to modulate IL-1β production. J Immunol. (Baltimore, Md: 1950) 191(10):5239–5246. https://doi.org/10.4049/jimmunol.1301581

doi: 10.4049/jimmunol.1301581 pubmed: 24123685

Mascarenhas DPA, Cerqueira DM, Pereira MSF, Castanheira FVS, Fernandes TD, Manin GZ et al (2017) Inhibition of caspase-1 or gasdermin-D enable caspase-8 activation in the Naip5/NLRC4/ASC inflammasome. PLoS Pathog 13(8):e1006502. https://doi.org/10.1371/journal.ppat.1006502

doi: 10.1371/journal.ppat.1006502 pubmed: 28771586 pmcid: 5542441

Rauch I, Deets KA, Ji DX, von Moltke J, Tenthorey JL, Lee AY et al (2017) NAIP-NLRC4 Inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of Caspase-1 and -8. Immunity 46(4):649–659. https://doi.org/10.1016/j.immuni.2017.03.016

doi: 10.1016/j.immuni.2017.03.016 pubmed: 28410991 pmcid: 5476318

Semper RP, Vieth M, Gerhard M, Mejías-Luque R (2019) Helicobacter pylori exploits the NLRC4 inflammasome to dampen host defenses. J Immunol 203(8):2183. https://doi.org/10.4049/jimmunol.1900351

doi: 10.4049/jimmunol.1900351 pubmed: 31511355

Thomas CJ, Schroder K (2013) Pattern recognition receptor function in neutrophils. Trends Immunol 34(7):317–328. https://doi.org/10.1016/j.it.2013.02.008

doi: 10.1016/j.it.2013.02.008 pubmed: 23540649

Akkaya I, Oylumlu E, Ozel I, Uzel G, Durmus L, Ciraci C (2021) NLRC4 Inflammasome-mediated regulation of eosinophilic functions. Immune Netw 21(6):e42-e. https://doi.org/10.4110/in.2021.21.e42

doi: 10.4110/in.2021.21.e42

Gutierrez O, Pipaon C, Fernandez-Luna JL (2004) Ipaf is upregulated by tumor necrosis factor-alpha in human leukemia cells. FEBS Lett 568(1–3):79–82. https://doi.org/10.1016/j.febslet.2004.04.095

doi: 10.1016/j.febslet.2004.04.095 pubmed: 15196924

Sadasivam S, Gupta S, Radha V, Batta K, Kundu TK, Swarup G (2005) Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis. Oncogene 24(4):627–636. https://doi.org/10.1038/sj.onc.1208201

doi: 10.1038/sj.onc.1208201 pubmed: 15580302

Nordlander S, Pott J, Maloy KJ (2014) NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. Mucosal Immunol 7(4):775–785. https://doi.org/10.1038/mi.2013.95

doi: 10.1038/mi.2013.95 pubmed: 24280936

Hausmann A, Böck D, Geiser P, Berthold DL, Fattinger SA, Furter M et al (2020) Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the adapted pathogen salmonella Typhimurium due to site-specific bacterial PAMP expression. Mucosal Immunol 13(3):530–544. https://doi.org/10.1038/s41385-019-0247-0

doi: 10.1038/s41385-019-0247-0 pubmed: 31953493 pmcid: 7181392

Janowski AM, Colegio OR, Hornick EE, McNiff JM, Martin MD, Badovinac VP et al (2016) NLRC4 suppresses melanoma tumor progression independently of inflammasome activation. J Clin Invest 126(10):3917–3928. https://doi.org/10.1172/JCI86953

doi: 10.1172/JCI86953 pubmed: 27617861 pmcid: 5096827

DeYoung KL, Ray ME, Su YA, Anzick SL, Johnstone RW, Trapani JA et al (1997) Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene 15(4):453–457. https://doi.org/10.1038/sj.onc.1201206

doi: 10.1038/sj.onc.1201206 pubmed: 9242382

Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR et al (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458(7237):514–518. https://doi.org/10.1038/nature07725

doi: 10.1038/nature07725 pubmed: 19158675 pmcid: 2726264

Fernandes-Alnemri T, Yu J-W, Juliana C, Solorzano L, Kang S, Wu J et al (2010) The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11(5):385–393. https://doi.org/10.1038/ni.1859

doi: 10.1038/ni.1859 pubmed: 20351693 pmcid: 3111085

Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H et al (2009) An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10(3):266–272. https://doi.org/10.1038/ni.1702

doi: 10.1038/ni.1702 pubmed: 19158679

Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S et al (2009) HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science (New York, NY) 323(5917):1057–1060. https://doi.org/10.1126/science.1169841

doi: 10.1126/science.1169841

Lugrin J, Martinon F (2018) The AIM2 inflammasome: Sensor of pathogens and cellular perturbations. 281(1):99–114. https://doi.org/10.1111/imr.12618

Sharma BR, Karki R, Kanneganti T-D (2019) Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur J Immunol 49(11):1998–2011. https://doi.org/10.1002/eji.201848070

doi: 10.1002/eji.201848070 pubmed: 31372985 pmcid: 7015662

Kumari P, Russo AJ, Shivcharan S, Rathinam VA (2020) AIM2 in health and disease: Inflammasome and beyond. Immunol Rev 297(1):83–95. https://doi.org/10.1111/imr.12903

doi: 10.1111/imr.12903 pubmed: 32713036 pmcid: 7668394

Rathinam VAK, Chan FK (2018) Inflammasome, inflammation, and tissue homeostasis. Trends Mol Med 24(3):304–318. https://doi.org/10.1016/j.molmed.2018.01.004

doi: 10.1016/j.molmed.2018.01.004 pubmed: 29433944 pmcid: 6456255

Saiga H, Kitada S, Shimada Y, Kamiyama N, Okuyama M, Makino M et al (2012) Critical role of AIM2 in mycobacterium tuberculosis infection. Int Immunol 24(10):637–644. https://doi.org/10.1093/intimm/dxs062

doi: 10.1093/intimm/dxs062 pubmed: 22695634

Hanamsagar R, Aldrich A, Kielian T (2014) Critical role for the AIM2 inflammasome during acute CNS bacterial infection. 129(4):704–711. https://doi.org/10.1111/jnc.12669

Fang R, Tsuchiya K, Kawamura I, Shen Y, Hara H, Sakai S et al (2011) Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J Immunol 187(9):4890. https://doi.org/10.4049/jimmunol.1100381

doi: 10.4049/jimmunol.1100381 pubmed: 21957143

Kalantari P, DeOliveira RB, Chan J, Corbett Y, Rathinam V, Stutz A et al (2014) Dual engagement of the NLRP3 and AIM2 inflammasomes by plasmodium-derived hemozoin and DNA during malaria. Cell Rep 6(1):196–210. https://doi.org/10.1016/j.celrep.2013.12.014

doi: 10.1016/j.celrep.2013.12.014 pubmed: 24388751 pmcid: 4105362

Fisch D, Bando H, Clough B, Hornung V, Yamamoto M, Shenoy AR et al (2019) Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis. EMBO J 38(13):e100926. https://doi.org/10.15252/embj.2018100926

doi: 10.15252/embj.2018100926 pubmed: 31268602 pmcid: 6600649

Reinholz M, Kawakami Y, Salzer S, Kreuter A, Dombrowski Y, Koglin S et al (2013) HPV16 activates the AIM2 inflammasome in keratinocytes. Arch Dermatol Res 305(8):723–732. https://doi.org/10.1007/s00403-013-1375-0

doi: 10.1007/s00403-013-1375-0 pubmed: 23764897

Yogarajah T, Ong KC, Perera D, Wong KT (2017) AIM2 Inflammasome-mediated Pyroptosis in enterovirus A71-infected neuronal cells restricts viral replication. Sci Rep 7(1):5845. https://doi.org/10.1038/s41598-017-05589-2

doi: 10.1038/s41598-017-05589-2 pubmed: 28724943 pmcid: 5517550

Ekchariyawat P, Hamel R, Bernard E, Wichit S, Surasombatpattana P, Talignani L et al (2015) Inflammasome signaling pathways exert antiviral effect against chikungunya virus in human dermal fibroblasts. Infect Genet Evol 32:401 –408. https://doi.org/10.1016/j.meegid.2015.03.025

doi: 10.1016/j.meegid.2015.03.025 pubmed: 25847693

Man SM, Karki R, Kanneganti TD (2016) AIM2 inflammasome in infection, cancer, and autoimmunity: role in DNA sensing, inflammation, and innate immunity. Eur J Immunol 46(2):269–280. https://doi.org/10.1002/eji.201545839

doi: 10.1002/eji.201545839 pubmed: 26626159

Wang B, Tian Y, Yin Q (2019) AIM2 Inflammasome assembly and Signaling. Adv Exp Med Biol 1172:143 –155. https://doi.org/10.1007/978-981-13-9367-9_7

doi: 10.1007/978-981-13-9367-9_7 pubmed: 31628655

Wang B, Yin Q (2017) AIM2 inflammasome activation and regulation: a structural perspective. J Struct Biol 200(3):279–282. https://doi.org/10.1016/j.jsb.2017.08.001

doi: 10.1016/j.jsb.2017.08.001 pubmed: 28813641 pmcid: 5733693

Pierini R, Juruj C, Perret M, Jones CL, Mangeot P, Weiss DS et al (2012) AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell Death Differ 19(10):1709–1721. https://doi.org/10.1038/cdd.2012.51

doi: 10.1038/cdd.2012.51 pubmed: 22555457 pmcid: 3438500

El-Zaatari M, Bishu S, Zhang M, Grasberger H, Hou G, Haley H et al (2020) Aim2-mediated/IFN-β-independent regulation of gastric metaplastic lesions via CD8+ T cells. JCI Insight 5(5). https://doi.org/10.1172/jci.insight.94035

Svensson A, Patzi Churqui M, Schlüter K, Lind L, Eriksson K (2017) Maturation-dependent expression of AIM2 in human B-cells. PLoS One 12(8):e0183268-e. https://doi.org/10.1371/journal.pone.0183268

doi: 10.1371/journal.pone.0183268

Harris J, Lang T, Thomas JPW, Sukkar MB, Nabar NR, Kehrl JH (2017) Autophagy and inflammasomes. Mol Immunol 86:10 –15. https://doi.org/10.1016/j.molimm.2017.02.013

doi: 10.1016/j.molimm.2017.02.013 pubmed: 28249679

Liu T, Tang Q, Liu K, Xie W, Liu X, Wang H et al (2016) TRIM11 suppresses AIM2 Inflammasome by degrading AIM2 via p62-dependent selective autophagy. Cell Rep 16(7):1988–2002. https://doi.org/10.1016/j.celrep.2016.07.019

doi: 10.1016/j.celrep.2016.07.019 pubmed: 27498865

Rodrigue-Gervais IG, Doiron K, Champagne C, Mayes L, Leiva-Torres GA, Vanié P et al (2018) The mitochondrial protease HtrA2 restricts the NLRP3 and AIM2 inflammasomes. Sci Rep 8(1):8446. https://doi.org/10.1038/s41598-018-26603-1

doi: 10.1038/s41598-018-26603-1 pubmed: 29855523 pmcid: 5981608

Schnappauf O, Chae JJ, Kastner DL, Aksentijevich I (2019) The pyrin Inflammasome in health and disease. Front Immunol 10:1745 . https://doi.org/10.3389/fimmu.2019.01745

doi: 10.3389/fimmu.2019.01745 pubmed: 31456795 pmcid: 6698799

Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ et al (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production. J Proc Natl Acad Sci 103(26):9982–9987. https://doi.org/10.1073/pnas.0602081103

Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD et al (2007) The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 14(8):1457–1466. https://doi.org/10.1038/sj.cdd.4402142

doi: 10.1038/sj.cdd.4402142 pubmed: 17431422

Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP et al (2003) Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 11(3):591–604. https://doi.org/10.1016/s1097-2765(03)00056-x

doi: 10.1016/s1097-2765(03)00056-x pubmed: 12667444

Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S et al (2006) Cryopyrin and pyrin activate caspase-1, but not NF-κB, via ASC oligomerization. Cell Death Differ 13(2):236–249. https://doi.org/10.1038/sj.cdd.4401734

doi: 10.1038/sj.cdd.4401734 pubmed: 16037825

Xu H, Yang J, Gao W, Li L, Li P, Zhang L et al (2014) Innate immune sensing of bacterial modifications of rho GTPases by the pyrin inflammasome. Nature 513(7517):237–241. https://doi.org/10.1038/nature13449

doi: 10.1038/nature13449 pubmed: 24919149

Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17(8):914–921. https://doi.org/10.1038/ni.3457

doi: 10.1038/ni.3457 pubmed: 27270401 pmcid: 4955684

Yu J-W, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, Solorzano L et al (2007) Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell 28(2):214–227. https://doi.org/10.1016/j.molcel.2007.08.029

doi: 10.1016/j.molcel.2007.08.029 pubmed: 17964261 pmcid: 2719761

Starnes TW, Bennin DA, Bing X, Eickhoff JC, Grahf DC, Bellak JM et al (2014) The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood 123(17):2703–2714. https://doi.org/10.1182/blood-2013-07-516948

doi: 10.1182/blood-2013-07-516948 pubmed: 24421327 pmcid: 3999755

Journal

Informations de publication

Résumé

Identifiants

Substances chimiques

Types de publication

Langues

Sous-ensembles de citation

Pagination

Informations de copyright

Références

Auteurs

Vinicius Nunes Cordeiro Leal (VNC)

Alessandra Pontillo (A)

Articles similaires

Lipid accumulation in adipose tissue-resident iNKT cells contributes to an inflammatory phenotype.

Myosin-binding protein-H: Not just filler.

Exploring transcriptomic mechanisms underlying pulmonary adaptation to diverse environments in Indian rams.

Calcineurin inhibition enhances

Classifications MeSH